This article will compare KBWB to KBWR and posit a trade that takes both of these into account. Read more about KBWB ETF here.Read full newsRead More
I expect Crown Holdings' capex to decrease and free cash flow to increase from next year onwards. Here's what that means for owners of CCK stock.Read full newsRead More
American Lithium Corp has been able to gather up some quality sites to capture the growing demand for lithium. Read more about AMLI here.Read full newsRead More
JPMorgan produced a massive profit of $12.6B in Q1 on $39.3B of revenue. Read more about JPM here.Read full newsRead More
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week.Read full newsRead More
The AI battle between Microsoft (MSFT) and Google (GOOG) is heating up, with the former taking on the offensive, integrating GPT-4 capabilities in product offerings. Read more here.Read full newsRead More
UFP Industries faces a tough start to 2023 with a double-digit revenue decline. Learn why UFPI stock looks undervalued.Read full newsRead More
Compared to its peers, based on forward earnings, Becton, Dickinson is the cheapest of the bunch. Read more about BDX here.Read full newsRead More
Jane's retirement accounts generated a total of $3,249.92 of dividend income for March 2023 vs. $2,838.34 for March 2022. See more for an update on the portfolio.Read full newsRead More
Antero Midstream Corporation stock is cheap, trading at only 10 times EBITDA. This gives AM easily at least 15% upside from the current price. Click here for more.Read full newsRead More
High frequency indicators can give us a nearly up-to-the-moment view of the economy. Read more here.Read full newsRead More
NIO continues to burn significant levels of cash to grow its business in the increasingly competitive Chinese EV market. See why I rate NIO stock as a Hold.Read full newsRead More
Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for fibrosis and related diseases. Read more here.Read full newsRead More
Earnings season is here, with 87% of the S&P reporting in the next month. Read why AMZN, BTI, and USB are three of my blue-chip Buy recommendations.Read full newsRead More
AbbVie is in a period of transition as they are no longer protected by the excellence of Humira. Click here to see why ABBV stock is a Hold.Read full newsRead More
Werner's growth and profitability indicators point towards a promising trajectory, but investors should approach WERN cautiously due to potential headwinds. Read more here.Read full newsRead More
Gildan is the largest manufacturer of low-cost basic apparel for the Printwear industry, producing roughly 1.2 billion shirts per year.Read full newsRead More
Global business activity rose in March at the fastest rate for nine months.Read full newsRead More
S&P Global's Egypt PMI continued to signal multiple headwinds on the private sector economy in March, rounding off a bleak first quarter of 2023.Read full newsRead More
Steven Madden's stock price might have seen an uptick this week, but its fundamentals do not indicate that this can continue. See why I rate SHOO stock a Sell.Read full newsRead More